Overview Archives - ProxsysRx

Overcome 340B ESP & Other Manufacturer Restrictions With Software And Human Insight

August 28, 2024340B, 340B ESP, Bedside Prescription Delivery, Contract Pharmacy, Covered Entities, Drug Manufacturer Restrictions, Meds To Beds, Overview, Specialty Drugs, Specialty Pharmacy, TPA / TPAs

POST OUTLINE PHASE ONE: Organizing 340B data, coordinating teams Connecting and educating 340B system providers Requalifying all eligible, but unreimbursed, 340B scripts Retrieving 340B eligible-script data Establishing communication lines between internal and external 340B teams Why specialized software is essential for successful 340B programs The central problem with most 340B programs’ data Why 340B software … Read More

How 340B Programs Can Positively Impact Value-Based Care Scores

March 9, 2023340B, Bedside Prescription Delivery, CMS Star Ratings, Covered Entities, Medicare, Medication Compliance, Meds To Beds, Meds To Beds, Outpatient Tracking, Overview, Patient Eligibility, Readmissions Reduction, Value-Based Care

It’s no secret that, for hospitals, one of the Affordable Care Act’s most far-reaching legacies is the impact that Value-Based Care has on the payments they receive. For many health systems, the lower their Value-Based Care scores, the lower the payments they receive from treating Medicare and Medicaid patients. What isn’t as commonly considered — … Read More

What Is Your Health System’s Potential ROI With An Optimized 340B Program?

October 24, 2022340B, 340B ESP, Contract Pharmacy, Overview, Patient Eligibility, Specialty Drugs, Specialty Pharmacy

Introducing ProxsysRx’s 340B Program ROI Calculator The 340B program has often been described, and with good reason, as a black box. There are dozens of factors impacting an individual hospital’s relative success or failure in generating positive returns from a program. ProxsysRx has optimized dozens of 340B programs — generating tens of millions in savings … Read More

340B ESP. Why It’s Wrong, And How Hospitals Can Deal With It.

August 9, 2022340B, Compliance, Covered Entities, Overview, PBM, Requirements, Uncategorized

(NOTE: Over the years, we’ve served dozens of non-profit hospitals. We’ve seen the profound impact the 340B program has had in supporting their missions of serving the most vulnerable members of their communities. That said, we apologize, in advance, for the stridency of our tone on this page — but not for our sense of … Read More

340B Best Practices You Need To Know

April 1, 2022340B, Audit, Bedside Prescription Delivery, Compliance, Contract Pharmacy, Covered Entities, Meds To Beds, Overview, Patient Eligibility, Requirements, Specialty Pharmacy, Specialty Pharmacy

If your hospital is 340B-eligible, you may be missing-out on millions of dollars in prescription reimbursements. Savings and revenue which, for some hospitals served by ProxsysRx, actually make the difference between solvency and closure. Any list of Best Practices for running a 340B program starts with maintaining compliance. Tips for maintaining 340B Program Compliance The … Read More

How To Optimize 340B Programs

February 19, 2022340B, Compliance, Contract Pharmacy, Overview, Requirements

Getting started with the 340B Program The first step in preparing your health system for enrollment in the 340B program is to ensure that you’re eligible to participate. If your hospital isn’t already registered, you might want to refer to our previous blog post, Are you ready to enroll in the 340B program? Why 340B … Read More

What is the 340B Drug Pricing Program?

October 11, 2021340B, Compliance, Overview, Requirements

The 340B drug pricing program was created by Congress in 1992 to provide significant discounts on prescription drugs for certain health care providers. Its purpose is to help reduce costs and fill revenue gaps for those providers. The program allows eligible hospitals, clinics, pharmacies, nursing homes, home healthcare agencies, hospices, dialysis centers and long-term acute … Read More